TG THERAPEUTICS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Tg Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
Tg Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 145 %, a 35.3% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	145	-78.9	-35.3%	Sep 30, 2024
Q2 2024	116	-149	-56.1%	Jun 30, 2024
Q1 2024	139	-34.1	-19.7%	Mar 31, 2024
Q4 2023	174	+63.7	+57.5%	Dec 31, 2023
Q3 2023	224	+143	+177%	Sep 30, 2023
Q2 2023	266			Jun 30, 2023
Q1 2023	173			Mar 31, 2023
Q4 2022	111			Dec 31, 2022
Q3 2022	80.9			Sep 30, 2022
Q4 2012	55.6			Dec 31, 2012
Q3 2012	59.6			Sep 30, 2012
Q2 2012	112			Jun 30, 2012
Q1 2012	262			Mar 31, 2012

* An asterisk sign (*) next to the value indicates that the value is likely invalid.